Financial statements Novopharma
Balance sheet of Novopharma
Company age:
Age:
16 y. 6 m. 7 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of NOVOPHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 214 356,39 | 244 913,16 | 226 959,29 | 450 964,04 | 480 614,22 | 523 931,48 |
| A. Fixed assets | 2 153,58 | 1 665,94 | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 212 202,81 | 243 247,22 | 226 959,29 | 450 964,04 | 480 614,22 | 523 931,48 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 214 356,39 | 244 913,16 | 226 959,29 | 450 964,04 | 480 614,22 | 523 931,48 |
| A. Equity | 110 624,43 | 102 879,42 | 140 581,53 | 376 385,49 | 396 754,35 | 403 787,88 |
| B. Liabilities and provisions for liabilities | 103 731,96 | 142 033,74 | 86 377,76 | 74 578,55 | 83 859,87 | 120 143,60 |
| I. Long-term liabilities | 18 335,00 | 48 399,00 | 36 483,00 | 24 567,00 | 12 651,00 | 2 380,00 |
| II. Short-term liabilities | 85 396,96 | 93 634,74 | 49 894,76 | 50 011,55 | 71 208,87 | 117 763,60 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.